Latest Health News
- Obesity Stigma Depends on Where You LivePeople living in areas where obesity is more common may experience less stigma, which could help reduce some of the social and health consequences of being overweight.
- FDA OKs Implantable Treatment for Diabetic Macular EdemaThe FDA has approved a new implantable treatment for adults with diabetic macular edema (DME) after studies showed that it could help maintain vision with as few as two treatments per year.
- Hospitalized for Cannabis? Your Risk of Early Death May Rise People who get hospital-based care for cannabis use disorder have a 2.8-fold greater chance of dying within the next five years than people who were of the same age and otherwise had similar health factors.
- Forever Chemicals Are Everywhere. Here’s How to Stress LessIf you're looking for calm in a toxic world, read advice from scientists who study environmental stress.
- FDA OKs New Wearable Infusion Device for Parkinson’sThe FDA has approved Onapgo, a new wearable device for adults with advanced Parkinson’s disease that gives a steady dose of apomorphine under the skin to help manage movement issues and daily symptom changes.
- Fitness Reduces Dementia Risk, Even in Those at Genetic RiskStaying fit is one of the best ways to lower the risk of dementia — even for those with a genetic predisposition to the condition.
- FDA Approves New Drug Combination for Mantle Cell LymphomaThe FDA has approved a new pill to treat adults with a type of blood cancer called mantle cell lymphoma (MCL).
- 1 in 5 Older Adults Take Aspirin—But Some Shouldn’tTaking a daily aspirin? It could be worth asking yourself why, and if it’s still the best choice for you.
- Scientists Are Finding More Microplastics in the BrainMicroplastics have been found in the brain, showing they can cross the blood-brain barrier, and the amounts of the tiny plastic bits inside our bodies appear to be increasing at a rate that reflects the increasing amount of global plastic waste.
- Ultraprocessed Foods Linked to Preschooler Obesity RiskDuring the two quick years when a child is considered a preschooler, a diet high in ultraprocessed foods may put them at risk of developing overweight or obesity by the time they start kindergarten.
- FDA Approves New Non-Opioid Pain TreatmentThe FDA has approved suzetrigine (Journavx), a new non-opioid oral drug for acute pain in adults – the first new class of non-opioid pain medicine approved in over 20 years.
- The Skinny on ‘Smart’ Fitness Clothing in 2025“Smart” athleticwear can now monitor the same fitness and health stats as a watch or phone app. Is it ready for general use?
- What Experts Say Kids Should and Shouldn’t Be DrinkingNew recommendations say people ages 5 to 18 years old should drink mainly water and pasteurized milk. Basically, if a nutrition label mentions added sugar, they shouldn’t drink it.
- FDA OKs Ozempic for Kidney Disease in Diabetes PatientsThe FDA has approved Novo Nordisk's diabetes drug Ozempic to help reduce the risk of worsening kidney disease, kidney failure, and heart-related death in adults with type 2 diabetes and chronic kidney disease (CKD).
- Kansas Struggles to Contain Worsening TB OutbreakTwo counties in the Kansas City area continue to grapple with what is now a yearlong outbreak of tuberculosis.
- Norovirus Myths You Should Stop BelievingNorovirus, which many people call “stomach flu,” is actually an illness in your gut, while the flu is a respiratory infection. Read about other common myths and wrong ideas about the virus.
- Cannabis Use Can Reduce Working Memory: Study Cannabis use can significantly impact the part of the brain responsible for following instructions, responding during conversations, or remembering a question long enough to answer it. This type of cognitive function is a form of short-term memory called working memory.
- Losing Your Voice? Here’s What to KnowVoice disorders are on the rise. We asked experts how to keep speaking loud and clear.
- FDA Approves Drug for Hard-to-Treat Breast CancerThe FDA has approved fam-trastuzumab deruxtecan, marketed under the brand name Enhertu, as a new treatment for certain types of advanced breast cancer that have spread or cannot be removed with surgery.
- What to Know About the New Nasal Spray for Tough DepressionThe FDA’s latest approval of the nasal spray Spravato (esketamine) CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more medication.
- FDA Approves New Prep Regimen for Bone Marrow TransplantThe FDA has approved a new treatment, Grafapex, to help people get ready for a bone marrow transplant.
- Feeling the Winter Blues? Notice Nature for a Well-Being BoostLearn why paying attention to nature and how it makes you feel can enhance your mental health this season.
- People With ADHD May Face Shorter Life ExpectancyThe life expectancy of people with attention deficit hyperactivity disorder (ADHD) may be significantly shorter than that of people who don’t have the disorder, a new study suggests.
- Wildfires and Mental Health: Community First, Then TherapyJust after a wildfire disaster, receiving good support from the community ranks high in aiding mental health, and opening up about feelings and frustrations should come when evacuees are ready, experts say.
- FDA Approves New Treatment for Advanced Breast CancerThe FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.
Recommended